Stefano Fanti
Stefano Fanti
Professore di Diagnostica per Immagini
Verified email at unibo.it
TitleCited byYear
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
E Zamagni, F Patriarca, C Nanni, B Zannetti, E Englaro, A Pezzi, ...
Blood 118 (23), 5989-5995, 2011
3122011
Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered forá…
JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ...
Journal of Nuclear Medicine 56 (8), 1185-1190, 2015
2992015
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
I Virgolini, V Ambrosini, JB Bomanji, RP Baum, S Fanti, M Gabriel, ...
European journal of nuclear medicine and molecular imaging 37 (10), 2004-2010, 2010
2682010
Detection and localization of prostate cancer: correlation of 11C-choline PET/CT with histopathologic step-section analysis
M Farsad, R Schiavina, P Castellucci, C Nanni, B Corti, G Martorana, ...
Journal of Nuclear Medicine 46 (10), 1642-1649, 2005
2642005
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in theá…
E Zamagni, C Nanni, F Patriarca, E Englaro, P Castellucci, O Geatti, ...
Haematologica 92 (1), 50-55, 2007
2512007
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison withá…
R Schiavina, V Scattoni, P Castellucci, M Picchio, B Corti, A Briganti, ...
European urology 54 (2), 392-401, 2008
2472008
Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
P Castellucci, C Fuccio, C Nanni, I Santi, A Rizzello, F Lodi, ...
Journal of Nuclear Medicine 50 (9), 1394-1400, 2009
2332009
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
V Ambrosini, P Tomassetti, P Castellucci, D Campana, G Montini, ...
European journal of nuclear medicine and molecular imaging 35 (8), 1431-1438, 2008
2272008
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS de Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
2242015
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
V Ambrosini, D Campana, L Bodei, C Nanni, P Castellucci, V Allegri, ...
Journal of Nuclear Medicine 51 (5), 669-673, 2010
2232010
Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
V Prasad, V Ambrosini, M Hommann, D Hoersch, S Fanti, RP Baum
European journal of nuclear medicine and molecular imaging 37 (1), 67, 2010
2172010
Prostate Cancer: Sextant Localization with MR Imaging, MR Spectroscopy, and 11C-Choline PET/CT1
C Testa, R Schiavina, R Lodi, E Salizzoni, B Corti, M Farsad, ...
Radiology 244 (3), 797-806, 2007
2052007
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment ofá…
M Picchio, A Briganti, S Fanti, A Heidenreich, BJ Krause, C Messa, ...
European urology 59 (1), 51-60, 2011
2032011
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy
C Capirci, L Rampin, PA Erba, F Galeotti, G Crepaldi, E Banti, M Gava, ...
European journal of nuclear medicine and molecular imaging 34 (10), 1583-1593, 2007
1952007
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ...
European journal of nuclear medicine and molecular imaging 42 (8), 1284-1294, 2015
1922015
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours
A Chiti, S Fanti, G Savelli, A Romeo, B Bellanova, M Rodari, ...
European journal of nuclear medicine 25 (10), 1396-1403, 1998
1781998
Radiopeptide imaging and therapy in Europe
V Ambrosini, M Fani, S Fanti, F Forrer, HR Maecke
Journal of Nuclear Medicine 52 (2), 42S, 2011
1772011
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
1692018
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis
C Rapezzi, CC Quarta, PL Guidalotti, C Pettinato, S Fanti, O Leone, ...
JACC: Cardiovascular Imaging 4 (6), 659-670, 2011
1612011
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, andá…
P Castellucci, AM Perrone, M Picchio, T Ghi, M Farsad, C Nanni, C Messa, ...
Nuclear medicine communications 28 (8), 589-595, 2007
1602007
The system can't perform the operation now. Try again later.
Articles 1–20